Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 08 Dec 2023

Minding the gaps: assessing and addressing clinical research core competencies across a network of Canadian cancer centres

in Drugs Outcomes Research and Policies

Stephen Sundquist
Diana Kato
Raisa Chowdhury
Christine Samara
Janet E. Dancey

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1294335

1,947 views
1 citation

Curriculum, Instruction, and Pedagogy

Published on 07 Dec 2023

The development of a clinical research educational training for community health workers using the joint task force for clinical trial competency framework

in Drugs Outcomes Research and Policies

Amin Yakubov
Dina Pimenova
Alzahraa Ahmed
Romelia Corvacho
Joanna Madigan
Jay Naik
Chen Lyu
Anita McFarlane
Victoria Foster
Megan Haseltine

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1295281

4,460 views
7 citations

Curriculum, Instruction, and Pedagogy

Published on 06 Dec 2023

Development of an undergraduate certificate in clinical and translational science: improving competence of the clinical research workforce

in Drugs Outcomes Research and Policies

Jacqueline Knapke
Michelle Marcum
Angela Mendell
Patrick Ryan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1294534

1,789 views
1 citation

Perspective

Published on 06 Dec 2023

A novel cross-institutional college internship program to train future diverse leaders in clinical research with data-driven approaches to assess impact

in Drugs Outcomes Research and Policies

Julia Derk
Kafui Dzirasa
Tracie Locklear

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1294535

2,357 views
1 citation

Original Research

Published on 05 Dec 2023

A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation

in Drugs Outcomes Research and Policies

Xiao-Yuan Zheng
Guang-Wei Feng
Jing Guo
Fen Xie
Xia Li
Ming-Zhu Zhang
Xiu-Fen Zhang
Xiu-Feng Wu
Yong-Juan Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1286559

1,676 views

Original Research

Published on 04 Dec 2023

Price increase negotiations to address drug shortages in South Korea’s national health insurance

in Drugs Outcomes Research and Policies

Seung Rae Yu
Jong Hyuk Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1307462

6,368 views
4 citations

Original Research

Published on 04 Dec 2023

Online information and availability of three doping substances (anabolic agents) in sports: role of pharmacies

in Drugs Outcomes Research and Policies

Juan F. Garcia
Jesús Seco-Calvo
Soledad Arribalzaga
Raquel Díez
Cristina Lopez
M. Nelida Fernandez
Juan J. Garcia
M. Jose Diez
Raul de la Puente
Matilde Sierra

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1305080

4,050 views
2 citations

Original Research

Published on 04 Dec 2023

Impact of early heparin therapy on outcomes in patients with solid malignancy associated sepsis: a marginal structural model causal analyse

in Drugs Outcomes Research and Policies

Jia-jia Huang
Ji-zhen Cai
Zhi-peng Zhou
Yan Liu
Zhen-jia Yang
Da-zheng Li
Yu-hua Chen
Ying-yi Luan
Yong-ming Yao
Ming Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1281235

2,758 views
2 citations

Original Research

Published on 30 Nov 2023

Evaluating the effectiveness of the Ministry of Health restriction policy on seasonal antibiotic consumption trends in Saudi Arabia, 2016–2020

in Drugs Outcomes Research and Policies

Khaloud O. Alzahrani
Saeed M. Alshahrani
Sulaiman M. Alajel

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242087

4,327 views
2 citations

Original Research

Published on 28 Nov 2023

Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries

in Drugs Outcomes Research and Policies

Juan Carlos Rejon-Parrilla
Jaime Espin
Sarah Garner
Stanislav Kniazkov
David Epstein

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199500

9,894 views
7 citations

Perspective

Published on 28 Nov 2023

Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer

in Drugs Outcomes Research and Policies

Alessandra I. G. Buma
Berber Piet
Rob ter Heine
Michel M. van den Heuvel
Paul Brinkman
Daan van den Broek
Sjaak Burgers
Francesco Ciompi
Simona M. Cristescu
Bram van Ginneken

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274532

2,560 views
6 citations

Opinion

Published on 24 Nov 2023

Leveraging stories of cardiac amyloidosis patients of African ancestry or descent to support patient-derived data elements for efficient diagnosis and treatment

in Drugs Outcomes Research and Policies

Rachele M. Hendricks-Sturrup
Lauren M. Edgar
Christine Y. Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1276396

1,420 views
1 citation

Methods

Published on 24 Nov 2023

Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes

in Drugs Outcomes Research and Policies

Karolina Zebrowska
Rosa C. Banuelos
Evelyn J. Rizzo
Kathy W. Belk
Gary Schneider
Koen Degeling

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1249998

2,352 views
3 citations

Review

Published on 23 Nov 2023

Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges

in Drugs Outcomes Research and Policies

Xin Chen
Ruyue He
Xinyi Chen
Liyun Jiang
Fei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1261312

3,463 views
5 citations

Original Research

Published on 22 Nov 2023

Enhancing phase I dose-finding trials design through dynamic borrowing information and handling late-onset toxicity

in Drugs Outcomes Research and Policies

Wenyun Yang
Ruyue He
Yuehan Sun
Fangrong Yan
Fei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1266322

1,580 views

Correction

Published on 22 Nov 2023

Corrigendum: Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study

in Drugs Outcomes Research and Policies

Geok Ying Chun
Nurul Ain Mohd Tahir
Farida Islahudin
Veena Selvaratnam
Shu Chuen Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1336072

648 views